CBT vs FUL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CBT

55.6
AI Score
VS
CBT Wins

FUL

49.5
AI Score

Investment Advisor Scores

CBT

56score
Recommendation
STRONG BUY

FUL

50score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CBT FUL Winner
Forward P/E 9.9404 9.4429 FUL
PEG Ratio 1.0017 2.2026 CBT
Revenue Growth 6.4% 5.2% CBT
Earnings Growth -93.7% 18.0% FUL
Tradestie Score 55.6/100 49.5/100 CBT
Profit Margin 5.2% 5.6% FUL
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY CBT

Relative Price Performance (Last 90 Days)

CBT 1M: -5.7% · 3M: -17.5% FUL 1M: +1.4% · 3M: -8.6%

Current Technical Phase

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $74.33

FUL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.4 · Price: $50.89

Fundamentals Snapshot

Metric CBT FUL
Market Cap — —
Forward P/E 10.6 9.9
Trailing P/E 20.7 14.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.1%
EPS 3.57 3.59
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.